(Q54621891)

English

A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

A phase II double-blind study to investigate efficacy and safety of two doses of the triple angiokinase inhibitor BIBF 1120 in patients with relapsed advanced non-small-cell lung cancer. (English)

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

0 references

author name string

M Reck

1

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

R Kaiser

2

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

C Eschbach

3

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

M Stefanic

4

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

J Love

5

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

U Gatzemeier

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

P Stopfer

7

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

J von Pawel

8

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

publication date

6 January 2011

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

Annals of Oncology

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

22

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

6

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

1374-1381

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

The role of vascular endothelial growth factor in pathological angiogenesis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Vascular endothelial growth factor: basic science and clinical progress

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Multicenter, phase II trial of sunitinib in previously treated, advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Clinical evaluation of ZD6474, an orally active inhibitor of VEGF and EGF receptor signaling, in patients with solid, malignant tumors

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Angiogenesis as a Prognostic Indicator of Survival in Non-Small-Cell Lung Carcinoma: a Prospective Study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Angiogenesis: An indicator of metastasis in non-small cell lung cancer invading the thoracic inlet

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDQ618

21 January 2018

Identifiers

10.1093/ANNONC/MDQ618

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

1 reference

Europe PubMed Central

1 June 2018

http://europepmc.org/abstract/MED/21212157

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54621891&oldid=917360018"